“Intravenous alteplase is safe and effective in routine clinical use when given within 3h of stroke onset
Information for Authors
BMJ Opinion provides comment and opinion written by The BMJ's international community of readers, authors, and editors.
We welcome submissions for consideration. Your article should be clear, compelling, and appeal to our international readership of doctors and other health professionals. The best pieces make a single topical point. They are well argued with new insights.